Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration

We investigated whether polygenic risk score (PRS) was associated with one-year outcome of as-needed aflibercept therapy for exudative age-related macular degeneration (AMD), including AMD (n = 129) and polypoidal choroidal vasculopathy (n = 132). A total of 261 patients were treated with as-needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shijo, Taiyo, Sakurada, Yoichi, Yoneyama, Seigo, Kikushima, Wataru, Sugiyama, Atsushi, Matsubara, Mio, Fukuda, Yoshiko, Mabuchi, Fumihiko, Kashiwagi, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559528/
https://www.ncbi.nlm.nih.gov/pubmed/32962278
http://dx.doi.org/10.3390/ph13090257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559528/
https://www.ncbi.nlm.nih.gov/pubmed/32962278
http://dx.doi.org/10.3390/ph13090257

Ejemplares similares